SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.
马萨诸塞州比勒里卡，2022 年 9 月 6 日（GLOBE NEWSWIRE）——为合作伙伴关系提供生命科学仪器和研究服务的科技公司 SeqLL Inc.（“SeqLL” 或 “公司”）（纳斯达克股票代码：SQL；SQLLW）今天宣布，SeqLL 首席执行官丹尼尔·琼斯将在即将举行的 H.C. Wainwright 上介绍公司概况并出席虚拟 1x1 会议 24第四 年度全球会议将于 2022 年 9 月 12 日至 14 日举行。
The presentation will be available on demand beginning at 7:00 am ET on Monday, September 12th. To view the presentation or request a 1x1 meeting, click HERE to register and attend the event.
该演示将从美国东部时间9月12日星期一上午 7:00 开始按需提供第四。要查看演示文稿或申请 1x1 会议，请单击此处注册并参加活动。
About SeqLL Inc.
SeqLL Inc. ("SeqLL") is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple "omics" fields. The Company leverages its expertise with its True Single Molecule Sequencing ("tSMS®") platform to empower scientists and researchers with improved genetic tools to better understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with today's precision medicine. In sum, our experienced team works with our collaborators to develop innovative solutions tailored to the needs of each specific project.
关于 SeqLL Inc.
SeqLL Inc.（“SeqLL”）是一家科技公司，通过合作伙伴关系提供生命科学仪器和研究服务，旨在开发多个 “组学” 领域的新型科学资产和知识产权。该公司利用其真单分子测序（“tSMS®”）平台的专业知识，为科学家和研究人员提供改进的遗传工具，以更好地了解疾病的分子机制，这对于基因组医学新突破的持续发展至关重要，并有望解决当今精准医疗所涉及的关键问题。总而言之，我们经验丰富的团队与合作者合作，开发针对每个特定项目的需求量身定制的创新解决方案。
Contacts:
Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com
联系人：
阿什莉·罗宾逊
LifeSci 顾问有限公司
电话：+1 (617) 430-7577
电子邮件：arr@lifesciadvisors.com
译文内容由第三方软件翻译。